ADALIMUMAB THERAPY FOR INFLIXIMAB FAILURES IN CROHN'S DISEASE. A SINGLE-CENTRE UK EXPERIENCE

被引:0
|
作者
Sprakes, M. B. [1 ]
Ford, A. C. [1 ]
Warren, L. [1 ]
Greer, D. [1 ]
Donnellan, C. F. [1 ]
Jennings, J. S. R. [1 ]
Everett, S. M. [1 ]
Hamlin, P. J. [1 ]
机构
[1] Leeds Gen Infirm, Dept Gastroenterol, Leeds, W Yorkshire, England
关键词
D O I
10.1136/gut.2009.208967h
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A99 / A100
页数:2
相关论文
共 50 条
  • [1] Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience
    Sprakes, M. B.
    Ford, A. C.
    Suares, N. C.
    Warren, L.
    Greer, D.
    Donnellan, C. F.
    Jennings, J. S. R.
    Everett, S. M.
    Hamlin, P. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (11-12) : 1357 - 1363
  • [2] Adalimumab for Crohn's disease with intolerance or lost response to infliximab: a 3-year single-centre experience
    Oussalah, A.
    Babouri, A.
    Chevaux, J. -B.
    Stancu, L.
    Trouilloud, I.
    Bensenane, M.
    Boucekkinet, T.
    Bigard, M. -A.
    Peyrin-Biroulet, L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (04) : 416 - 423
  • [3] PREDICTORS OF RESPONSE AND LOSS OF RESPONSE TO INFLIXIMAB THERAPY FOR CROHN'S DISEASE: A LARGE UK SINGLE CENTRE EXPERIENCE
    Sprakes, M.
    Ford, A. C.
    Warren, L.
    Greer, D.
    Hamlin, P. J.
    GUT, 2011, 60 : A218 - A218
  • [4] Adalimumab Treatment for Post-Operative Recurrence of Crohn's Disease. A Single Centre Experience
    Pratico, Chiara
    Rizzello, Fernando
    Calabrese, Carlo
    Straforini, Giulia
    Brugnera, Ramona
    Poggioli, Gilberto
    Laureti, Silvio
    Gionchetti, Paolo
    GASTROENTEROLOGY, 2013, 144 (05) : S442 - S442
  • [5] Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study
    Zorzi, F.
    Zuzzi, S.
    Onali, S.
    Calabrese, E.
    Condino, G.
    Petruzziello, C.
    Ascolani, M.
    Pallone, F.
    Biancone, L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (12) : 1397 - 1407
  • [6] Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience
    Guidi, L.
    Ratto, C.
    Semeraro, S.
    Roberto, I.
    De Vitis, I.
    Papa, A.
    Marzo, M.
    Parello, A.
    Foglietto, G.
    Doglietto, G. B.
    Gasbarrini, G. B.
    Fedeli, G.
    TECHNIQUES IN COLOPROCTOLOGY, 2008, 12 (02) : 111 - 117
  • [7] Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn’s disease with anal endosonographic monitoring: a single-centre experience
    L. Guidi
    C. Ratto
    S. Semeraro
    I. Roberto
    I. De Vitis
    A. Papa
    M. Marzo
    A. Parello
    G. Foglietto
    G. B. Doglietto
    G. B. Gasbarrini
    G. Fedeli
    Techniques in Coloproctology, 2008, 12 : 111 - 117
  • [8] THE LARGEST SINGLE-CENTRE EXPERIENCE WITH STENT THERAPY IN CROHN'S DISEASE - A REPORT ON OUTCOMES
    Das, Ronit
    Singh, Rajeev
    Din, Said
    Lund, Jonathan
    Krishnamoorthy, Rajesh
    Hearing, Stephen
    Norton, Bernard
    Williams, Jessica
    Chilkunda, Deepika
    Fraser, Catherine
    Goddard, Andrew
    Cole, Andrew
    GUT, 2019, 68 : A66 - A68
  • [9] Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience
    Suares, N. C.
    Hamlin, P. J.
    Greer, D. P.
    Warren, L.
    Clark, T.
    Ford, A. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (02) : 284 - 291
  • [10] Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: A large single centre experience
    Sprakes, Michael B.
    Ford, Alexander C.
    Warren, Lisa
    Greer, Dan
    Hamlin, John
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (02): : 143 - 153